Type-specific EV-D68 real-time RT-PCR assay for the detection of all extant enterovirus D68 strains
Open Access
- 20 August 2025
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 63 (9) , e0149222
Abstract
We developed a type-specific Enterovirus D68 (EV-D68) real-time RT-PCR (rRT-PCR) assay termed CDC2022, which targets sequences encoding conserved amino acid regions of all extant EV-D68 strains. We targeted three motifs conserved among all strains in the last 60 years. The assay achieved 100% (281/281) sensitivity and 100% (344/344) specificity when tested with a collection of 625 respiratory specimens, compared to the gold-standard EV semi-nested VP1 PCR and sequencing assay (snPCR/Seq). CDC2022 gave negative results with 289/289 non-target viruses, including 104 EV A-D isolates, 165 rhinovirus (RV) isolates or clinical specimens, and 14 other common respiratory viruses. The limit of detection (LOD) of the CDC2022 assay is 361 copies per reaction, as determined using serially diluted RNA transcripts. It can detect as few as 0.28 CCID 50 per reaction with titrated isolates. An in silico “phylo-primer-mismatch" analysis was performed to visualize primer/probe mismatches and to compare CDC2022 with other EV-D68 rRT-PCR assays. It showed that CDC2022 has the fewest primer/probe mismatches among all assays analyzed and is suitable for all clades. As a type-specific assay targeting conserved amino acids, the CDC2022 assay allowed detection of newer strains from 2024. The CDC 2022 assay could provide a critical tool for molecular surveillance of EV-D68. IMPORTANCE: EV-D68 has caused recurring respiratory disease outbreaks in the United States since 2014. As recurrent outbreaks and continued virus evolution are expected for EV-D68, the CDC2022 rRT-PCR provides a robust test that detects known strains as well as potential emerging strains. This type-specific assay approach is critical for national EV-D68 surveillance and clinical diagnostics. An in silico “phylo-primer-mismatch" approach is invented to show EV-D68 assay robustness, but it has utility in new molecular tests for pathogen detection.Keywords
All Related Versions
This publication has 23 references indexed in Scilit:
- Enterovirus D68–Associated Respiratory Illness in ChildrenJAMA Network Open, 2025
- Enterovirus D68 in the Anterior Horn Cells of a Child with Acute Flaccid MyelitisNew England Journal of Medicine, 2022
- Outbreak of Enterovirus D68 Among Children in Japan—Worldwide Circulation of Enterovirus D68 Clade B3 in 2018The Pediatric Infectious Disease Journal, 2020
- Pan-viral serology implicates enteroviruses in acute flaccid myelitisNature Medicine, 2019
- Development of single-step multiplex real-time RT-PCR assays for rapid diagnosis of enterovirus 71, coxsackievirus A6, and A16 in patients with hand, foot, and mouth diseaseJournal of Virological Methods, 2017
- Worldwide emergence of multiple clades of enterovirus 68Journal of General Virology, 2012
- Comparative evaluation of Taqman real-time PCR and semi-nested VP1 PCR for detection of enteroviruses in clinical specimensJournal of Clinical Virology, 2010
- Rapid detection of Enterovirus 71 by real-time TaqMan RT-PCRJournal of Clinical Virology, 2008
- MAFFT version 5: improvement in accuracy of multiple sequence alignmentNucleic Acids Research, 2005
- A PROBABLE NEW HUMAN PICORNAVIRUS ASSOCIATED WITH RESPIRATORY DISEASE1American Journal of Epidemiology, 1967